Transcription factor NKX2.1 promotes differentiation of induced pluripotent stem cells into lung stem cells

doi:10.12307/2025.566

Abstract

Abstract: BACKGROUND: Enhancing the differentiation of induced pluripotent stem cells into lung stem cells is crucial for repairing lung injuries. NKX2.1 is the earliest marker of lung epithelial differentiation and plays a significant regulatory role in lung development. However, the impact of its expression on the differentiation of induced pluripotent stem cells into lung stem cells remains inadequately understood.
OBJECTIVE: To investigate the effect of NKX2.1 on the differentiation of induced pluripotent stem cells into lung stem cells.
METHODS: Induced pluripotent stem cells were cultured in vitro. The expression of specific pluripotent stem cell genes was assessed using real-time fluorescence quantitative PCR. NKX2.1 was overexpressed in induced pluripotent stem cells, which were then induced to differentiate into lung stem cells. The expression of FoxA2, SOX9, and P63 was determined via quantitative PCR and immunofluorescence on day 7 of induction of differentiation. The expression of the alveolar marker SPB and SPC was evaluated through immunofluorescence staining on day 7 of induction of differentiation.
RESULTS AND CONCLUSION: (1) Induced pluripotent stem cells in vitro were tightly packed and showed typical clonoid growth and significantly expressed stem cell-specific genes OCT-4, SOX2, and NANOG. (2) Compared with the non-transfected control group, the expression of NKX2.1 in human induced pluripotent stem cells was significantly increased in the NKX2.1 overexpression group (P < 0.000 1). (3) Seven days after induction of differentiation, compared with the non-transfected control group, the expression of lung stem cell-related markers FoxA2, SOX9, and P63 was significantly increased in the NKX2.1 overexpression group (P < 0.000 1). (4) Thirteen days after induction of differentiation, compared with the non-transfected control group, the fluorescence intensity of alveolar cell marker molecules SPB and SPC increased significantly in the overexpression NKX2.1 group. The results show that NKX2.1 can promote the differentiation of induced pluripotent stem cells into lung stem cells.

Key words: induced pluripotent stem cell, lung stem cell, NKX2.1, definitive endoderm, foregut endoderm, lung injury, engineered stem cell

CLC Number:

Deng Li, Liu Yang, Wang Hui, Yang Qiu, Dong Mingqing. Transcription factor NKX2.1 promotes differentiation of induced pluripotent stem cells into lung stem cells[J]. Chinese Journal of Tissue Engineering Research, 2025, 29(36): 7790-7796.

Figures/Tables 2

References

[1] VAZQUEZ-ARMENDARIZ AI, TATA PR. Recent advances in lung organoid development and applications in disease modeling. J Clin Invest. 2023;133(22):e170500.
[2] LEAVY OC, KAWANO-DOURADO L, STEWART ID, et al. Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study. Thorax. 2024;79(6):538-544.
[3] OLSON AL, SWIGRIS JJ, SPRUNGER DB, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372-378.
[4] GENC AC, OZTURK Z, KARA AB, et al. Assessment of the clinical features of rheumatoid arthritis-related interstitial lung diseases: a retrospective evaluation. Eur Rev Med Pharmacol Sci. 2023;27(18):8486-8493.
[5] SOLOMON JJ, DANOFF SK, WOODHEAD FA, et al. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med. 2023;11(1):87-96.
[6] PALOMÄKI A, FINNGEN RHEUMATOLOGY CLINICAL EXPERT GROUP, PALOTIE A, et al. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers. Ann Rheum Dis. 2021;80(12):1530-1536.
[7] ALYSANDRATOS KD, GARCIA-DE-ALBA C, YAO C, et al. Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells. JCI Insight. 2023;8(1):e158937.
[8] DYE BR, DEDHIA PH, MILLER AJ, et al. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. Elife. 2016;5:e19732.
[9] ANTONI D, BURCKEL H, JOSSET E, et al. Three-dimensional cell culture: a breakthrough in vivo. Int J Mol Sci. 2015;16(3):5517-5527.
[10] KLEIN SG, SERCHI T, HOFFMANN L, et al. An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung. Part Fibre Toxicol. 2013;10:31.
[11] KÜHL L, GRAICHEN P, VON DAACKE N, et al. Human Lung Organoids-A Novel Experimental and Precision Medicine Approach. Cells. 2023; 12(16):2067.
[12] SUN YL, HENNESSEY EE, HEINS H, et al. Human pluripotent stem cell modeling of alveolar type 2 cell dysfunction caused by ABCA3 mutations. J Clin Invest. 2024;134(2):e164274.
[13] KITAMURA T, MISU M, YOSHIKAWA M, et al. Differentiation of embryonic stem cells into lung-like cells using lung-derived matrix sheets. Biochem Biophys Res Commun. 2023;686:149197.
[14] LI T, SU X, LU P, et al. Bone Marrow Mesenchymal Stem Cell-Derived Dermcidin-Containing Migrasomes enhance LC3-Associated Phagocytosis of Pulmonary Macrophages and Protect against Post-Stroke Pneumonia. Adv Sci (Weinh). 2023;10(22):e2206432;
[15] 李强,张明伟,李建明,等.miR-146b促进诱导多能干细胞向神经元样细胞的分化[J].中国组织工程研究,2018,22(17):2711-2716.
[16] 伟人悦,厉雪纯,李妍,等.无血清单层细胞诱导法培养猪诱导多能性干细胞定向分化为血管内皮细胞[J].中国组织工程研究,2020, 24(31):4971-4978.
[17] ALBER AB, MARQUEZ HA, MA L, et al. Directed differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme. Nat Commun. 2023;14(1):3488.
[18] KANAGAKI S, IKEO S, SUEZAWA T, et al. Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition. Stem Cells. 2021;39(2):156-169.
[19] HEIN RFC, CONCHOLA AS, FINE AS, et al. Stable iPSC-derived NKX2-1+ lung bud tip progenitor organoids give rise to airway and alveolar cell types. Development. 2022;149(20):dev200693.
[20] LAZZARO D, PRICE M, DE FELICE M, et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development. 1991;113(4): 1093-1104.
[21] MINOO P, SU G, DRUM H, et al. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dev Biol. 1999; 209(1):60-71.
[22] LITTLE DR, GERNER-MAURO KN, FLODBY P, et al. Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1. Proc Natl Acad Sci U S A. 2019;116(41): 20545-20555.
[23] KUWAHARA A, LEWIS AE, COOMBES C, et al. Delineating the early transcriptional specification of the mammalian trachea and esophagus. Elife. 2020;9:e55526.
[24] TOTH A, KANNAN P, SNOWBALL J, et al. Alveolar epithelial progenitor cells require Nkx2-1 to maintain progenitor-specific epigenomic state during lung homeostasis and regeneration. Nat Commun. 2023; 14(1):8452.
[25] LITTLE DR, LYNCH AM, YAN Y, et al. Differential chromatin binding of the lung lineage transcription factor NKX2-1 resolves opposing murine alveolar cell fates in vivo. Nat Commun. 2021;12(1):2509.
[26] OSTRIN EJ, LITTLE DR, GERNER-MAURO KN, et al. β-Catenin maintains lung epithelial progenitors after lung specification. Development. 2018;145(5):dev160788.
[27] KUSAKABE T, KAWAGUCHI A, HOSHI N, et al. Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol Endocrinol. 2006;20(8):1796-1809.
[28] GHAEDI M, CALLE EA, MENDEZ JJ, et al. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J Clin Invest. 2013;123(11):4950-4962.
[29] YAMAMOTO Y, GOTOH S, KOROGI Y, et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat Methods. 2017;14(11):1097-1106.
[30] LIAKOULI V, CIANCIO A, DEL GALDO F, et al. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nat Rev Rheumatol. 2024;20(1):21-32.
[31] BEERS MF, MORRISEY EE. The three R’s of lung health and disease: repair, remodeling, and regeneration. J Clin Invest. 2011;121(6): 2065-2073.
[32] ALDER JK, BARKAUSKAS CE, LIMJUNYAWONG N, et al. Telomere dysfunction causes alveolar stem cell failure. Proc Natl Acad Sci U S A. 2015;112(16):5099-5104.
[33] MATTHAY MA, ARABI Y, ARROLIGA AC, et al. A New Global Definition of Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(1):37-47.
[34] MATTHAY MA, ZEMANS RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147-163.
[35] 李福东,刘虹,陈亚君,等.肺干细胞向肺泡上皮分化在急性呼吸窘迫综合征中的研究进展[J].医学研究杂志,2022,51(6):21-24.
[36] 张红蕾,聂宏光.干细胞治疗肺损伤的研究进展[J].生理科学进展, 2019,50(4):277-280.
[37] MILLER AJ, HILL DR, NAGY MS, et al. In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells. Stem Cell Reports. 2018;10(1):101-119.
[38] BEERS MF, MOODLEY Y. When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. Am J Respir Cell Mol Biol. 2017;57(1):18-27.
[39] ZHOU L, LIM L, COSTA RH, et al. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem. 1996;44(10):1183-1193.
[40] MIURA A, SARMAH H, TANAKA J, et al. Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lung. Elife. 2023;12:e86105.
[41] WANG Y, MENG Z, LIU M, et al. Autologous transplantation of P63+ lung progenitor cells for chronic obstructive pulmonary disease therapy. Sci Transl Med. 2024;16(734):eadi3360.
[42] MCCAULEY KB, HAWKINS F, SERRA M, et al. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. Cell Stem Cell. 2017;20(6): 844-857.e6.
[43] KONISHI S, GOTOH S, TATEISHI K, et al. Directed Induction of Functional Multi-ciliated Cells in Proximal Airway Epithelial Spheroids from Human Pluripotent Stem Cells. Stem Cell Reports. 2016;6(1):18-25.